Recombinant ICOS anticorps

N° du produit ABIN7828304

L’anticorps anti-ICOS Monoclonal Lapin est utilisé pour la détection de ICOS dans des échantillons de Humain. Il a été validé pour IHC.

Aperçu rapide pour Recombinant ICOS anticorps (ABIN7828304)

Antigène: ICOS (Inducible T-Cell Co-Stimulator (ICOS))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp ICOS est non-conjugé

Application: Immunohistochemistry (IHC)

Clone: A168

Détail du produit anti-ICOS anticorps

Fonction: Recombinant CD278/ICOS Monoclonal Antibody

Purification: Protein A purified

Immunogène: Recombinant human CD278/ICOS fragment

Isotype: IgG, kappa

Information d'application

Indications d'application: IHC 1:200-1:1000

Restrictions: For Research Use only

Stockage

Concentration: 1 mg/mL

Buffer: PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 % protein protectant.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.

Date de péremption: 12 months

Détails sur ICOS

Antigène: ICOS (Inducible T-Cell Co-Stimulator (ICOS))

Autre désignation: CD278/ICOS

Sujet: CVID,ICOS,AILIM,CD278,CVID1,activation-inducible lymphocyte immunomediatory molecule,Inducible T-cell costimulator,Enhances all basic T-cell responses to a foreign antigen, namely proliferation, secretion of lymphokines, up-regulation of molecules that mediate cell-cell interaction, and effective help for antibody secretion by B-cells. Essential both for efficient interaction between T and B-cells and for normal antibody responses to T-cell dependent antigens. Does not up-regulate the production of interleukin-2, but superinduces the synthesis of interleukin-10. Prevents the apoptosis of pre-activated T-cells. Plays a critical role in CD40-mediated class switching of immunoglobin isotypes. Cat.No. Product Name Clone No. IF:{{item.impact}} Journal:{{item.journal}} ({{item.year}}) DOI:{{item.doi}} Reactivity:{{item.species}} Sample Type:{{item.sample_type}} Previous {{ page }} Next Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}} Previous {{ page }} Next [

UniProt: Q9Y6W8

Pathways: Cancer Immune Checkpoints